HQL

H&Q life sciences Investors $19.76 1M -7.0% 3M +17.2% YTD +17.8% as of 2026-09-11
✓Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.0%
Next 1 week
-0.5%
Next 1 month
-1.6%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -2.9% median, 39% of the last 33 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 0
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.06%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.78 -0.1% · Seasonal tilt -1.5%
$3M/day volume 23% volatility +40% 1-year -57% from ATH
52-week range · 67% of the way up · -13% from the high
$13.88$22.67

Congressional trades in HQL Full tracker →

2 members · 6 buys / 3 sells · $9K–$135K disclosed · latest filing Nov 3, 2022.

SELL TC Thomas R Carper · traded Oct 4, 2022 $1K–$15K
BUY TC Thomas R Carper · traded Feb 22, 2020 $1K–$15K
BUY TC Thomas R Carper · traded Feb 22, 2020 $1K–$15K
SELL RG Raúl M. Grijalva · traded Sep 19, 2016 $1K–$15K
BUY RG Raúl M. Grijalva · traded Feb 12, 2016 $1K–$15K
BUY RG Raúl M. Grijalva · traded Jan 13, 2016 $1K–$15K
BUY RG Raúl M. Grijalva · traded Oct 15, 2015 $1K–$15K
SELL RG Raúl M. Grijalva · traded Jul 14, 2015 $1K–$15K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.